Figure 1: Reticulonodular growth pattern (H&E, x200).
Figure 2: CK8/18 positivity in tumor cells (x100).
Figure 3: S-100 positivity in tumor cells (x100).
Figure 4: EMA positivity in tumor cells (x100).
The patient presented at the Dicle University Medical Faculty Orthopedics Outpatients Department a year later with similar symptoms. A preliminary diagnosis of recurrent parachordoma was made and the mass was excised. The recurrent tumor's microscopy revealed marked atypical features, pleomorphism and a high degree of mitotic activity. The first pathology material had 2-3 mitoses/10 hpf while this value was 6-7 mitoses/10 hpf in the recurrent pathology material. A diagnosis of recurrent parachordoma was made. Close follow-up was suggested due to the marked atypical findings. The patient was healthy on 18-month follow-up.
Parachordomas are usually painless tumors and are encountered as slow-growing masses[4]. However, two painful cases with a subperiosteal location have been reported. The tumor was painful in our case and this was the reason for presentation. The tumor is well-limited and sometimes surrounded by a thin fibrous pseudocapsule. It is usually 3 to 7 mm in size and can grow up to 12 cm[3,4]. Our tumor was 7x4x3 cm in size. The section surface was shiny with a myxoid or gelatinous appearance, similar to other reports. Resection usually results in cure, and recurrences and metastases are rare[5]. Our case had a recurrence one year later. There are reports of a forearm parachordoma with lung metastasis[6] and a chest wall parachordoma with lymph node metastasis in the literature. Metastatic tumors are more cellular and the cells are more pleomorphic[7].
There are various theories about the histogenetic origin of parachordomas but there is no widely accepted view. They have been said to develop from progenitor cells with a chondroid differentiation capacity, the bone surface associated with tenosynovial or aponeurotic tissue or the periosteum, or subcutaneous tissues[4]. Parachordomas are thought to be related with ectopic notochord remnants, synovial tumors including synovial sarcomas and lipoblasts and chondroblasts. Most authors believe myoepithelial cell origin[8-9].
Low magnification reveals that the tumor consists of small nests of epithelioid cells, cords and pseudoglandular structures, together with a myxohyaline stroma. The proliferating cells have an abundant clear, pale eosinophilic cytoplasm similar to the physaliphorus cells of classical chordoma. The myxoid material is defined by intracytoplasmic vacuoles. Intracytoplasmic glycogen is demonstrated by PAS staining. The nucleus may vary from vesicular chromatin and prominent nucleoli to a small pyknotic form. Multinucleation is usually present. Mitotic activity is minimal. There is no lymphatic or vascular invasion. Some parachordomas have spindle cells with narrow cytoplasm and hyperchromatic nuclei arranged in cords and surrounded by a fibrous matrix. The stromal matrix can vary from pure myxoid to chondroid or hyalinelike composition[4].
This group of tumors show morphological heterogeneity. The differential diagnosis depends on the dominant cell type and stromal component and includes extraskeletal myxoid chondrosarcoma, chordoma, ossified fibromyxoid tumor, metastatic carcinoma, clear cell sarcoma, metastatic malignant melanoma and epithelioid sarcoma. Extraskeletal myxoid chondrosarcoma shows eosinophilic spindle cell cords that create multinodular patterns and ovoid cells within a myxoid matrix, and generally extends to the deep skeletal muscle. Extraskeletal myxoid chondrosarcomas have smaller cells that are more intensely eosinophilic with a less vacuolated cytoplasm than parachordoma cells[4]. Some extraskeletal myxoid chondrosarcoma cases stained with S-100[1]. Parachordomas generally express CK and especially CK8/18, while CK expression is not seen in extraskeletal myxoid chondrosarcomas[1]. Chordomas of sacral and vertebral location are seen in older patients and have a higher risk of recurrence due to both their histological characteristics and difficulty of achieving total surgical excision[10]. The microscopical features of chordomas and parachordomas are not very similar but a chondroid matrix is relatively rarer in parachordomas[1]. Our case was differentiated from a papillary thyroid carcinoma, indicated by the clear cells, with the negative thyroglobulin staining. Epithelioid sarcomas frequently express CK and EMA but S-100, GFAP and myogenic markers are negative. Melanomas typically express melanocytic antigens such as Melan-A, HMB-45 and S-100[1].
There are contradictory views on the surgical margins and recurrence association in the literature. Surgical treatment can provide a cure in parachordoma but tumors that have not been fully excised can recur[4]. Our case also had a recurrence a year later. There is no clear relationship between the status of the surgical margins and local recurrence but local recurrences and metastases are more frequent in patients with a histologically malignant appearance[1]. A pediatric myoepithelial carcinoma series in the literature has reported recurrence in 9 of 17 cases with negative surgical margins[11]. The specimen was piecemeal in our case and we were unable to evaluate the surgical margins. The histopathological appearance of the case indicated malignancy. Suggesting the cause of recurrence. There are reports of a forearm parachordoma with lung metastasis[6] and a chest wall parachordoma with lymph node metastasis in the literature. Metastatic tumors are more cellular and the cells are more pleomorphic[7]. Necrotic areas and nuclear atypia have been seen in metastatic tumors[12].
Parachordomas are benign tumors but metastases and recurrences are not unusual. Dabska[2] has reported recurrences after 7,2 and 12 years later but Niezabitowski et al.[13] have reported a recurrence at 3 months, Carstens et al. at 6 months and Ishida et al.[14] at 1 year although early recurrence is rare. However, it is difficult to determine the mean rate of recurrence due to the difficulty of a long time follow-up[5]. Two deaths from metastatic parachordoma have been reported in the literature and it has been said that parachordomas may potentially be low-grade sarcomas[5]. Parachordomas are benign tumors but they can become malignant when recurrence occurs after a short period and cases should therefore be followed-up closely.
1) Weiss SW, Goldblum JR: Enzinger & Weiss's Soft Tissue Tumors.
5th ed., Philadelphia, Mosby Elsevier, 2008, 1109-1116
2) Dabska M: Parachordoma: a new clinicopathologic entity. Cancer
1977, 40:1586-1592 [ Özet ]
3) Hornick JL, Fletcher CD: Myoepithelial tumors of soft tissue: a
clinicopathologic and immunohistochemical study of 101 cases
with evaluation of prognostic parameters. Am J Surg Pathol 1997,
27:1183-1196 [ Özet ]
4) Silverberg SG, DeLellis RA, Frable WJ, LiVolsi VA, Wick MR:
Silverberg's Principles and Practice of Surgical Pathology and
Cytopathology. 4th ed., Philadelphia, Churchill Livingstone,
2006, 395-396
5) Clabeaux J, Hojnowski L, Valente A, Damron TA: Case report:
parachordoma of soft tissues of the arm. Clin Orthop Relat Res
2008, 466:1251-1256 [ Özet ]
6) Guedes A, Barreto BG, Barreto LG, de Oliveira Araújo
IB, Queiroz AC, Athanazio DA, Athanazio PR: Metastatic
parachordoma. J Cutan Pathol 2009, 36:270-273 [ Özet ]
7) Limon J, Babińska M, Denis A, Ryś J, Niezabitowski A:
Parachordoma: a rare sarcoma with clonal chromosomal changes.
Cancer Genet Cytogenet 1998, 102:78-80 [ Özet ]
8) Kilpatrick SE, Hitchcock MG, Kraus MD, Calonje E, Fletcher
CD: Mixed tumors and myoepitheliomas of soft tissue: a
clinicopathologic study of 19 cases with a unifying concept. Am J
Surg Pathol 1997, 21:13-22 [ Özet ]
9) O'Connell JX, Berean KW: Parochordomas. Am J Surg Pathol
1997, 21:1120-1121 [ Özet ]
10) Sarsık B, Doğanavşargil B, Başdemir G , Zileli M, Sabah D,
Öztop F: Chordomas: Is it possible to predict recurrence? Turk
Patoloji Derg 2009, 25:27-34
11) Gleason BC, Fletcher CD: Myoepithelial carcinoma of soft tissue
in children: an aggressive neoplasm analyzed in a series of 29
cases. Am J Surg Pathol 2007, 31:1813-1824 [ Özet ]
12) Abe S, Imamura T, Harasawa A, Ishida T, Unno K, Tateishi
A, Tokizaki T, Yorikawa J, Matsushita T: Parachordoma with
multiple metastases. J Comput Assist Tomogr 2003, 27:634-638 [ Özet ]
13) Fisher C, Miettinen M: Parachordoma: a clinicopathologic and
immunohistochemical study of four cases of an unusual soft
tissue neoplasm. Ann Diagn Pathol 1997, 1:3-10 [ Özet ]
14) Ishida T, Oda H, Oka T, Imamura T, Machinami R:
Parachordoma: an ultrastructural and immunohistochemical
study. Virchows Arch A Pathol Anat Histopathol 1993, 422:
239-245 [ Özet ]